18 Apr 2024
16:00 CEST |
INTERPARFUMS |
Descriptif du programme de rachat d\'actions autorisé par l\'Assemblée générale mixte des actionnaires du 16 avril 2024
|
40204035 Cosmetics |
Other subject |
18 Apr 2024
15:00 CEST |
ATOS |
Atos renews its AWS Managed Service Provider (MSP) designation
|
10101010 Computer Services |
- |
18 Apr 2024
15:00 CEST |
ATOS |
Atos renouvelle son titre de fournisseur de services managés AWS (Managed Service Provider - MSP)
|
10101010 Computer Services |
- |
18 Apr 2024
14:27 CEST |
SCHNEIDER ELECTRIC SE |
Disclosure of Share Capital and Voting Rights Outstanding as of March 31,2024
|
50202010 Electrical Components |
Other subject |
18 Apr 2024
14:27 CEST |
SCHNEIDER ELECTRIC SE |
Nombre total de droits de vote et actions composant le capital social au 31 mars 2024
|
50202010 Electrical Components |
Other subject |
18 Apr 2024
13:14 CEST |
GENSIGHT BIOLOGICS |
GenSight Biologics met à disposition son Document d’Enregistrement Universel 2023
|
20103010 Biotechnology |
Commercial operations |
18 Apr 2024
13:14 CEST |
GENSIGHT BIOLOGICS |
GenSight Biologics Announces the Filing of its 2023 Universal Registration Document
|
20103010 Biotechnology |
Commercial operations |
18 Apr 2024
11:31 CEST |
LLEIDA |
Dutch postal operator to distribute Lleida.net's services exclusively in the Netherlands, and will be able to sell in Europe
|
10101020 Consumer Digital Services |
- |
18 Apr 2024
11:31 CEST |
LLEIDA |
El operador postal holandés distribuirá los servicios de Lleida.net en exclusiva en los Países Bajos, y podrá vender en Europa
|
10101020 Consumer Digital Services |
- |
18 Apr 2024
11:31 CEST |
LLEIDA |
L'opérateur postal néerlandais distribuera les services de Lleida.net en exclusivité aux Pays-Bas et pourra les vendre en Europe
|
10101020 Consumer Digital Services |
- |
18 Apr 2024
11:16 CEST |
VRANKEN-POMMERY |
Vranken-Pommery Monopole - Availability of the 2023 Reference Document (Including the Annual Financial Report)
|
45101015 Distillers and Vintners |
Other financial transaction |
18 Apr 2024
11:16 CEST |
VRANKEN-POMMERY |
VRANKEN-POMMERY MONOPOLE - MISE A DISPOSITION DU DOCUMENT DE REFERENCE 2023 (incluant le Rapport Financier Annuel)
|
45101015 Distillers and Vintners |
Other financial transaction |
18 Apr 2024
11:15 CEST |
S.E.B. |
Groupe SEB: Total Number of Shares and Voting Rights on the Date of Publication of the Preliminary Notice of Meeting – 15.03.2024
|
40202025 Household Equipment and Products |
General meeting / Board Meeting |
18 Apr 2024
11:15 CEST |
S.E.B. |
GROUPE SEB : NOMBRE D’ACTIONS ET DE DROITS DE VOTE A LA DATE DE PUBLICATION DE L’AVIS DE REUNION – 15.03.2024
|
40202025 Household Equipment and Products |
General meeting / Board Meeting |
18 Apr 2024
10:30 CEST |
S.E.B. |
Groupe SEB: Annual General Meeting of May 23, 2024
|
40202025 Household Equipment and Products |
General meeting / Board Meeting |
18 Apr 2024
10:30 CEST |
S.E.B. |
GROUPE SEB : ASSEMBLEE GENERALE MIXTE DU 23 MAI 2024
|
40202025 Household Equipment and Products |
General meeting / Board Meeting |
18 Apr 2024
08:30 CEST |
WE.CONNECT |
WE.CONNECT : FORTE CROISSANCE DES RÉSULTATS ANNUELS 2023 :
|
40401030 Specialty Retailers |
Other subject |
18 Apr 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences renforce son équipe opérationnelle avec l’arrivée d’une Responsable du développement et de la fabrication
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
08:00 CEST |
SEGRO PUBLIC LIMITED COMPANY |
SEGRO plc Trading Update
|
35102020 Industrial REITs |
Income |
18 Apr 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences further strengthens its operational team with the arrival of a Head of Development and Manufacturing
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
07:31 CEST |
DANONE |
DANONE : Bon démarrage de l’année ; Poursuite de la mise en œuvre de Renew Danone
|
45102020 Food Products |
New |
18 Apr 2024
07:31 CEST |
DANONE |
Danone: Good start to the year; Further delivering on Renew Danone
|
45102020 Food Products |
New |
18 Apr 2024
07:30 CEST |
VALLOUREC |
Vallourec progresses its holistic balance sheet refinancing with successful pricing of its 2032 Senior Notes offering
|
60101030 Oil Equipment and Services |
Other financial transaction |
18 Apr 2024
07:30 CEST |
FORVIA |
FIRST-QUARTER 2024 SALES
|
40101025 Auto Parts |
Sales |
18 Apr 2024
07:30 CEST |
MAUREL ET PROM |
Maurel & Prom: Q1 2024 Activity
|
60101010 Oil: Crude Producers |
Sales |
18 Apr 2024
07:30 CEST |
VALLOUREC |
Vallourec progresse dans le refinancement global de son bilan et annonce le succès du placement de ses obligations senior à échéance 2032
|
60101030 Oil Equipment and Services |
Other financial transaction |
18 Apr 2024
07:30 CEST |
FORVIA |
CHIFFRE D’AFFAIRES DU PREMIER TRIMESTRE 2024
|
40101025 Auto Parts |
Sales |
18 Apr 2024
07:30 CEST |
BOURSE DIRECT |
Bourse Direct : Premier trimestre 2024 : Chiffre d’affaires consolidé en hausse de 14,7% à 19,2 millions d’euros Croissance du recrutement de comptes en hausse de 28%
|
30202015 Investment Services |
Income |
18 Apr 2024
07:30 CEST |
MAUREL ET PROM |
Maurel & Prom : Activité T1 2024
|
60101010 Oil: Crude Producers |
Sales |
18 Apr 2024
07:03 CEST |
EDENRED |
Edenred : Q1 2024 revenue
|
50205015 Transaction Processing Services |
Corporate life |
18 Apr 2024
07:03 CEST |
EDENRED |
Edenred : Chiffre d\'affaires T1 2024
|
50205015 Transaction Processing Services |
Corporate life |
18 Apr 2024
07:02 CEST |
SARTORIUS STEDIM BIOTECH |
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
|
20102015 Medical Supplies |
Commercial results |
18 Apr 2024
07:02 CEST |
SARTORIUS STEDIM BIOTECH |
Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2024
|
20102015 Medical Supplies |
Commercial results |
18 Apr 2024
07:00 CEST |
BIOPHYTIS |
Biophytis announces new Scientific Advisory Board for its phase 2 OBA clinical study in obesity
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
07:00 CEST |
BIOPHYTIS |
Biophytis annonce la création d\'un Conseil Scientifique pour son étude clinique de phase 2 OBA dans l\'obésité
|
20103010 Biotechnology |
Other subject |